Press Releases for CRXX

Press Releases
FDA Extends NDA Review for Exalgo Extended-Release Tablets
Neuromed Receives FDA Feedback on New Drug Application for Exalgo Extended-Release Tablets
CombinatoRx Reports Financial Results for the Third Quarter 2009
CombinatoRx-Derived Combination Drug Candidate, Prednisporin, Acquired By Sanofi-Aventis Through Proposed Acquisition of Fovea Pharmaceuticals
CombinatoRx Reports Financial Results for the Second Quarter 2009
CombinatoRx to Webcast Conference Call Discussing Second Quarter 2009 Financial Results
CombinatoRx Publishes Research Demonstrating Improved Selectivity Through Synergistic Combinations
CombinatoRx and Neuromed Sign Merger Agreement
CombinatoRx Presents Full Data on Synavive Phase 2 Knee OA Trial at EULAR 2009
CombinatoRx Granted Extension to Regain NASDAQ Compliance
CombinatoRx Announces Positive Results for Aligned-Release Synavive
CombinatoRx Reports Positive Phase 2 Trial Results for CRx-401
CombinatoRx Receives NASDAQ Notification
CombinatoRx Abstract Accepted for Oral Presentation at EULAR 2009
CombinatoRx Reports Financial Results for the First Quarter 2009
CombinatoRx Announces Oncology Collaboration
CombinatoRx Collaborator Fovea Reports Encouraging Clinical Results with CombinatoRx-Derived Combination Drug Candidate
CombinatoRx to Webcast Conference Call Discussing First Quarter 2009 Financial Results
CombinatoRx to Present at Cowen 29th Annual Health Care Conference
CombinatoRx Reports Financial Results for the Fourth Quarter and Year End 2008
CombinatoRx to Webcast Conference Call Discussing Year End 2008 Financial Results
CombinatoRx to Present at 11th Annual BIO CEO & Investor Conference
CombinatoRx Publishes Data on Selective Amplification of Synergistic Combination Drug Candidate
CombinatoRx Presents New Data on B-Cell Malignancy Programs
CombinatoRx Announces Availability of Abstracts on ASH Website
CombinatoRx Concentrates on Core Strengths
CombinatoRx Reports Financial Results for the Third Quarter 2008
CombinatoRx to Present at Upcoming Investor Conferences
CombinatoRx to Webcast Conference Call Discussing Third Quarter 2008 Financial Results
CombinatoRx Provides In-Depth Analysis from Phase 2b Knee Osteoarthritis Study of Synavive (CRx-102) with Clinical Investigators
CombinatoRx to Present at the Seventh Annual BIO Investor Forum
CombinatoRx to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
CombinatoRx Announces Top-Line Results from Phase 2b Study of Synavive(TM) (CRx-102) for Knee Osteoarthritis
CombinatoRx Reports Financial Results for the Second Quarter 2008
CombinatoRx to Present at the Canaccord Adams 28th Annual Global Growth Conference
CombinatoRx to Webcast Conference Call Discussing Second Quarter 2008 Financial Results
CombinatoRx Highlights Progress in Key Programs at 2008 R&D Day
CombinatoRx to Host 2008 R&D Day Event
CombinatoRx to Present at the Third Annual Piper Jaffray Europe Conference
CombinatoRx to Present at the Canaccord Adams Diabetes & Obesity Conference
CombinatoRx Completes Enrollment in Phase 2B Clinical Trial of CRx-102 in Knee Osteoarthritis
CombinatoRx to Present at the FBR Capital Markets 12th Annual Spring Investor Conference - May 27 2008 1:01AM
CombinatoRx to Present at the Rodman & Renshaw Annual Global Healthcare Conference - Jun 1 2008 4:54PM
CombinatoRx Reports Financial Results for the First Quarter 2008 - Jun 1 2008 4:53PM
CombinatoRx to Webcast Conference Call Discussing First Quarter 2008 Financial Results